Phospho-VEGFR2 (Tyr1175) Rabbit Polyclonal Antibody

SKU: orb14809

Description

Phospho-VEGFR2 (Tyr1175) Rabbit Polyclonal Antibody

Research Area

Angiogenesis, Cancer Research, Cancer Research, Cell Markers, Cardiovascular Research, Endothelial Cells, Vascular, Growth Factors, Cancer Research, Host-Virus Interaction, Virology, Hypoxia, Receptor Tyrosne Kinases, Cell Biology, Surface Molecules, Molecular Biology, VEGF Receptors, Vascular, cardiovascular Research

Images & Validation

• Tested Applications: FC, WB
• Dilution Range: WB=1:500-2000, Flow-Cyt=2ug/test
• Reactivity: Human, Mouse, Rat
• Predicted Reactivity: Bovine, Canine, Equine, Porcine, Rabbit

Key Properties

• Antibody Type: Primary Antibody
• Host: Rabbit
• Clonality: Polyclonal
• Isotype: IgG
• Immunogen: KLH conjugated Synthesised phosphopeptide derived from human VEGFR2 around the phosphorylation site of Tyr1175 KD(p-Y)IV
• Target: KDR
• Molecular Weight: 147 kDa
• Purification: affinity purified by Protein A
• Conjugation: Unconjugated

Storage & Handling

• Storage: Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
• Form/Appearance: Liquid
• Buffer/Preservatives: 0.01M TBS (pH7.4) with 1% rAlbumin, 0.02% Proclin300 and 50% Glycerol.
• Concentration: 1mg/ml
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Alternative Names

VEGFR2(phospho-Tyr1175); VEGFR2(phospho-Y1175); p-VEGFR2(Tyr1175); p-VEGFR2(Y1175); CD309; CD309 antigen; Fetal liver kinase 1; FLK-1; FLK1; KDR; Kinase insert domain receptor(a type III receptor tyrosine kinase); Kinase insert domain receptor; KRD1; Ly73; Protein tyrosine kinase receptor FLK1; Protein-tyrosine kinase receptor flk-1; Tyrosine kinase growth factor receptor; Vascular endothelial growth factor receptor 2; VEGFR 2; VEGFR; VEGFR-2; VEGFR2; VGFR2_HUMAN.

Quick Database Links

Gene Symbol

KDR

UniProt

P35968

Pal, Sumanta K. et al. RNA-seq reveals aurora kinase-driven mTOR pathway activation in patients with sarcomatoid metastatic renal cell carcinoma Mol Cancer Res, 13, 130-137 (2015)

PubMed: 25183163